Skip to main content
Home
Latest news
Browse topics
Cardiovascular disorders Chronic kidney disease Diabetes devices & technology GLP-1 receptor agonists Hyperglycemia Hypoglycemia Obesity, diet, & lifestyle interventions SGLT2 inhibitors Type 1 diabetes Type 2 diabetes Browse all topics
EN
EN
In focus
Novel clinical evidence in continuous glucose monitoring Fasting for religion and health in people with diabetes The challenge of type 2 diabetes in children HFpEF & diabetes: Diagnosis and management in the wake of EMPEROR-Preserved Addressing suicide risk in diabetes: Rates and risk factors, HCP fears, and practical advice The SURPASS trials: Summarizing efficacy data on tirzepatide Semaglutide for weight loss: STEP and SELECT trials: Results from the STEP and SELECT trials Why psychosocial care matters DiRECT: Type 2 diabetes remission through weight management
Congress coverage
EASD 58th Annual Meeting 2022 The American Diabetes Association 82nd Scientific Sessions
About us
Medicine Matters Diabetes
EXTENDED SEARCH
4 search results for:

Chantal Mathieu 

sort by |
"newest" sorts results by publication date. "most relevant" also considers factors like how often the search phrase is in the result.
  1. 01-22-2019 | Insulin | News | Article

    Oral basal insulin not yet commercially viable despite good glycemic control

    In an accompanying comment Chantal Mathieu, from KU Leuven in Belgium, says that although the “robust” study opens up “a therapeutic pathway many patients and clinicians had already accepted would never become a reality,” it also reports “a level of variability in achieved glycaemic concentrations that is problematic.”

    Published in:
    Lancet Diabetes Endocrinol 2019; doi:10.1016/ S2213-8587(18)30372-3 Lancet Diabetes Endocrinol 2019; doi:10.1016/ S2213-8587(19)30005-1
  2. 10-05-2018 | Hyperglycemia | News | Article

    ADA/EASD consensus report on managing hyperglycemia in type 2 diabetes published

    Addressing the press, EASD Vice President Chantal Mathieu (KU Leuven, Belgium) emphasized the importance of the consensus report process in helping clinicians to decide “where we need to go in this forest of new glucose-lowering therapies.”

    Published in:
    Diabetologia 2018; doi:10.1007/s00125-018-4729-5 Diabetes Care 2018; doi:10.2337/dci18-0033 EASD Annual Meeting; Berlin, Germany: 1–5 October 2018
  3. 06-28-2018 | Dapagliflozin | News | Article

    DEPICT-2 confirms dapagliflozin efficacy in type 1 diabetes

    Chantal Mathieu (KU Leuven, Belgium), who presented the results to the press at the ADA’s 78th Scientific Sessions in Orlando, Florida, USA, said that time in range is a “very important parameter in my eyes as a clinician,” and stressed that the improvement seen with dapagliflozin “is in the same ballpark as what you can achieve with the almost closed-loop systems that we have at the moment.”

  4. 09-13-2017 | Acarbose | EASD 2017 | Article

    ACE results suggest no reduction in CV risk with acarbose treatment

    And in her commentary on the study, Chantal Mathieu (Katholieke Universiteit Leuven, Belgium) highlighted that although the ACE trial showed no effect of acarbose on the five-point composite cardiovascular endpoint, it was a “very well-designed, very well-powered study” showing that the drug is efficacious in preventing type 2 diabetes in an Asian population.

    Published in:
    Lancet Diabetes Endocrinol 2017; Advance online publication EASD 2017; Lisbon, Portugal: 11–15 September
  • 1

Filter search results

Search Operators:

„ ... ... “ Finds documents with exactly this word group, in exactly this word order and spelling (e.g., "employer branding").
AND Finds documents with both search terms (e.g., sales AND bonus).
OR Finds documents with one or the other search term (e.g., porsche OR volkswagen).
Blank Space Finds documents with all search terms. Blank space is understood as AND (e.g., man robot production).
NOT Finds documents with no appearance of the word behind NOT (e.g., ford NOT "harrison ford").
COUNT(...)>n Finds documents where the search term is mentioned at least "n" times."n" may be any number (e.g., COUNT(gear)>8).
NEAR(..., ..., ) Finds documents with both search terms in any word order, permitting "n" words as a maximum distance between them. Best choose between 15 and 30 (e.g., NEAR(recruit, professionals, 20)).
* Finds documents with the search term in word versions or composites. The star * marks whether you wish them BEFORE, BEHIND, or BEFORE and BEHIND the search term (e.g., lightweight*, *lightweight, *lightweight*).
? Finds documents with the search termn in different spellings."?" allows only one character (e.g., organi?ation).
& + - Special characters are understood as AND (e.g., Miller Bros. & Sons).

You can use operators in your search query to narrow down your results even more.

Tap the operator, or hover the mouse pointer over it, to read more about how it works.